An interventional randomized study to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes that have already been treated with basal insulin.
Study of LY3209590
18H-MC-BDCM
Study Length: 32 weeks
Target Age/Sex: over 18 years of age Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures
Link: ClinicalTrials.gov